Oxanabol Tablets

What Separates Oxandrolone From Every Other Oral Anabolic

Oxanabol Tablets contain Oxandrolone — the oral anabolic steroid with an anabolic:androgenic ratio of approximately 322–630:24. That ratio defines what Anavar does and who it is for: extremely high anabolic activity relative to androgenic potency. In practical terms, this means real, measurable muscle and strength gains with a side effect profile that is the mildest of any anabolic compound in the British Dragon lineup.

Oxandrolone is one of a very small number of performance compounds with documented safety across diverse clinical populations — including burn patients, paediatric patients, and postmenopausal women. It has been prescribed for decades for muscle wasting and osteoporosis. That clinical record reflects what athletes already know from practice: Anavar delivers genuine anabolic outcomes at a risk level that other compounds cannot match.

The Mechanism: Why Oxandrolone Builds Quality Gains

Oxandrolone is DHT-derived, which means it cannot aromatize under any conditions. There is no estrogen conversion, no water retention, and no estrogenic side effects at any dose. Unlike the Drostanolone compounds (Mastabol 100, Mastabol 200) or Mesterolone (Mesterolone Tablets), Oxandrolone's effect is not primarily through SHBG binding or receptor competition — it is a direct anabolic acting through its own receptor binding affinity, producing gains through nitrogen retention and phosphocreatine synthesis rather than through amplifying other compounds.

• Increases nitrogen retention — maintaining the positive nitrogen balance that drives muscle protein accretion, even in caloric deficit
• Significantly increases phosphocreatine synthesis in muscle tissue — the substrate responsible for rapid ATP regeneration. This explains why strength gains from Oxandrolone are disproportionately large relative to the mass gained. Powerlifters and weight-class athletes exploit this specifically
• Binds SHBG strongly — increases bioavailable free testosterone when run alongside a testosterone base, amplifying the anabolic environment of the full cycle
• Markedly reduces visceral fat — a clinically documented effect, particularly relevant during cutting phases

Dosing for Men and Women

The 10 mg tablet concentration of Oxanabol is the ideal format for precise dose management across both male and female protocols:

• Men — lean gaining protocol: 40–60 mg/day (4–6 tablets), split across two doses with food due to the 9–10 hour half-life. Produces clean lean mass and disproportionate strength gains over 6–8 weeks. Hepatotoxicity at this dose range is considerably lower than equivalent-duration Methandienone use, allowing slightly longer cycles.
• Men — cutting or pre-contest protocol: 50–80 mg/day (5–8 tablets) for 6 weeks. At higher doses, strength preservation in a deficit is pronounced, muscle hardness and vascularity increase, and no water retention issues compromise the physique's condition.
• Women — standard anabolic protocol: 5–15 mg/day (half to 1.5 tablets). At 10 mg/day, Oxandrolone produces consistent lean mass and strength gains in female athletes with minimal virilization risk. The 10 mg tablet allows precise half-tablet dosing at 5 mg for the most conservative female protocol.
• Women — upper-range protocol: 15–20 mg/day for experienced female athletes. Above 20 mg/day, virilization risk increases meaningfully — voice deepening and clitoral enlargement are irreversible and monitoring at this dose range is essential.

Most Effective Stacks with Oxanabol Tablets

• Oxanabol Tablets (10–15 mg/day) as a women's solo protocol or paired with Primobol 100 — for female athletes, Oxandrolone is the first and most evidence-supported choice. At 10–15 mg/day, it produces lean mass and strength gains over a 6–8 week cycle with the lowest virilization risk of any anabolic. Adding low-dose Methenolone Enanthate (Primobolan Depot, Primobol 100) — injectable and naturally low-androgenic — makes the cycle more anabolically potent without meaningfully increasing virilization risk, making this combination the most effective and best-tolerated anabolic protocol available to female athletes.
• Oxanabol Tablets (60 mg/day) + Clenbuterol Tablets — cutting and body recomposition stack. Oxandrolone at 60 mg/day drives nitrogen retention and muscle preservation through a caloric deficit; Clenbuterol's beta-2 agonist thermogenesis directly accelerates fat oxidation. Both compounds produce zero estrogenic activity and no water retention — the combined effect on physique condition during a diet is significantly superior to either compound used alone. This stack is equally well-suited to male and female athletes preparing for competition or a physique peak.
• Oxanabol Tablets (50 mg/day) + Mastabol 200 + Testabol Enanthate — men's long-cycle lean quality mass protocol. Testosterone Enanthate provides the hormonal base and primary anabolic driver; Drostanolone Enanthate (Mastabol 200) layers hardening, drying, anti-estrogenic receptor competition, and SHBG binding; Oxandrolone adds nitrogen retention, phosphocreatine synthesis, and additional SHBG binding through a different mechanism than Drostanolone, making the combined free testosterone elevation additive. The result is a lean, quality mass cycle that runs cleanly for 12–16 weeks with minimal estrogen management demands.

Side Effects: Understanding the Actual Risk

Oxanabol is the mildest oral anabolic in the British Dragon catalog — but mild does not mean risk-free:

• Hepatotoxicity (elevated ALT/AST) — 17α-alkylated and genuinely hepatotoxic, but measurably lower stress than equivalent-duration Methandienone, Stanozolol, or Oxymethalone use. Liver support with TUDCA (Ursocol) is still required. Oxandrolone's lower hepatotoxicity does allow slightly longer cycles (8–10 weeks) versus the 4–6 week limit applicable to more hepatotoxic orals.
• Cholesterol disruption (HDL suppression) — despite Oxandrolone's mild overall profile, its effect on HDL cholesterol can be significant and disproportionate to other side effects. Monitoring and cardiovascular support are appropriate, particularly at higher doses (60–80 mg/day in men).
• Natural testosterone suppression — present but milder than most compounds. Still requires a testosterone base for male cycles longer than 4–5 weeks and full PCT at cycle end.
• Androgenic effects (acne, hair loss in predisposed individuals) — considerably lower risk than most androgens due to the 24 androgenic rating, but not zero.
• Virilization in women (voice changes, clitoral enlargement, increased body hair) — at doses above 20 mg/day, risk increases meaningfully. At 10–15 mg/day the risk is low but individual sensitivity varies. Women should discontinue immediately if early virilization signs appear.

Post-Cycle Therapy

Oxandrolone's 9–10 hour half-life means it clears quickly. PCT timing for a standalone Anavar cycle can begin 1–2 days after the last tablet:

• Men: Clomiphene Tablets and/or Tamoxifen Tablets for 3–4 weeks. Suppression from Oxandrolone is milder than from most steroids, and PCT duration can be shorter than for heavily suppressive compounds
• For combined cycles where Oxandrolone is used alongside testosterone injectables, PCT timing follows the injectable ester's clearance window
• Women do not require PCT with standard SERM protocols but should allow appropriate recovery time between cycles

Conclusion

Oxanabol Tablets by British Dragon represent the most accessible entry point into structured oral anabolic use for athletes of either sex. The 10 mg tablet format provides complete dosing flexibility across the full male and female dose range — from a conservative 5 mg half-tablet female protocol to an advanced male 80 mg/day cut.

Where other compounds in the British Dragon lineup demand management experience and risk tolerance, Oxandrolone offers genuine anabolic performance at the lowest side effect threshold available. The quality of the gains — lean, hard, dry, with a strength output disproportionate to the mass added — reflects a compound that has earned its status as the most trusted oral anabolic in performance sport across five decades.